Literature DB >> 2513821

Molecular epidemiology of Pseudomonas aeruginosa--urinary tract infections in paraplegic patients.

D Worlitzsch1, C Wolz, K Botzenhart, M Hansis, H Burgdörfer, J W Ogle, G Döring.   

Abstract

84 Pseudomonas aeruginosa strains from 29 paraplegic patients with urinary tract infections (UTI) and from the water reservoirs of specialized wards in two German hospitals were typed using a P. aeruginosa-specific DNA probe. P. aeruginosa strains were present in 51% of all accessible water reservoirs, including sinks of wash-basins and toilets in the wards. 14 of the 29 patients with UTI (48%) were infected by P. aeruginosa strains which were also isolated from these sources. Groups of up to four patients were infected by single strains. Some of the strains persisted in the wards and were isolated from the water reservoirs five to eight months after causing UTI. 89.5% of the investigated water samples yielded P. aeruginosa strains which were identical with strains from up to nine other sites. The wide distribution of single P. aeruginosa genotypes in the ward, the isolation of strains causing UTI from rooms inaccessible to the patients, and the outbreak of UTI caused by single, identical P. aeruginosa strains in groups of patients within short time periods, suggest that the strains are distributed by the personnel rather than by the patients who for the most part are immobile.

Entities:  

Mesh:

Year:  1989        PMID: 2513821

Source DB:  PubMed          Journal:  Zentralbl Hyg Umweltmed        ISSN: 0934-8859


  5 in total

1.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Restriction enzyme and Southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis.

Authors:  J S Loutit; L S Tompkins
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

3.  What Makes Pseudomonas aeruginosa a Pathogen?

Authors:  Burkhard Tümmler
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

Authors:  A Dalhoff
Journal:  Infection       Date:  1994       Impact factor: 3.553

5.  Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit.

Authors:  G Döring; M Hörz; J Ortelt; H Grupp; C Wolz
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.